Wire Stories
Dr. Reddy�s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy�s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received approval from...